Antibiotic Treatment Guidelines

Introduction to Antibiotic Administration

For patients with suspected bacterial infections, the choice of antibiotic and administration route depends on various factors, including the type of infection, patient population, and availability of vascular access, as recommended by the Infectious Diseases Society of America and Intensive Care Medicine guidelines 1, 2

The standard adult dosage of cefepime is 2 grams every 8-12 hours when administered intravenously, but for intramuscular (IM) administration, the recommended dose is typically 1 gram due to volume and absorption considerations, as recommended by the Infectious Diseases Society of America 1
Ceftriaxone dosing is recommended at 50 mg/kg/day in children and 1-2 g/day in adults, administered once daily, as suggested by the American Academy of Pediatrics 3

The intramuscular (IM) route has absorption limitations compared to IV administration and can cause significant pain and tissue damage with large volumes, supporting the recommendation of 1 gram IM as the standard dose for most infections, as noted by the Infectious Diseases Society of America 1
The IM route is crucial when IV access is difficult or impossible, as stated by Intensive Care Medicine guidelines and supported by Critical Care Medicine society 2, 4

Cefepime is primarily indicated for Pseudomonas coverage, which is not typically the primary concern in community-acquired intra-abdominal abscesses, according to Clinical Infectious Diseases guidelines 5, 1
Ceftriaxone is an appropriate option for immediate antimicrobial coverage in patients with intra-abdominal abscess when vascular access is limited, due to its broad-spectrum activity against gram-positive and gram-negative pathogens, as recommended by Intensive Care Medicine guidelines and supported by the American Academy of Otolaryngology-Head and Neck Surgery 2, 6
Ceftriaxone has limited activity against Pseudomonas aeruginosa and should not be used as monotherapy for infections caused by this pathogen, as noted by Critical Care Medicine society 4

For patients with severe sepsis or septic shock, establishing IV access for more aggressive therapy would be necessary, according to Intensive Care Medicine guidelines 2
If the patient has risk factors for resistant organisms (healthcare exposure, prior antibiotics), broader coverage may be needed, as reported by Clinical Infectious Diseases guidelines 1
Ceftriaxone may be combined with metronidazole to improve anaerobic coverage in complicated intra-abdominal infections, as suggested by Clinical Infectious Diseases guidelines 7

Gentamicina IM is an alternative option when ceftriaxone is not appropriate, with a narrower spectrum of activity and a higher risk of toxicity, as noted by Critical Care Medicine society 8
In cases of treatment failure, gentamicina IM (240 mg) may be considered as an alternative, as reported by Clinical Infectious Diseases guidelines 8